Profound Medical Corp Stock Technical Analysis

Most Profound analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Profound stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Profound Medical Corp, talking to its executives and customers, or listening to Profound conference calls.

Profound Medical appears to be slightly risky, given 3 months investment horizon. Profound Medical Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.0918, which implies the firm had a 0.0918 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Profound Medical Corp, which you can use to evaluate the volatility of the company. Please evaluate Profound Medical's Coefficient Of Variation of 884.68, risk adjusted performance of 0.0945, and Semi Deviation of 3.15 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Profound Medical holds a performance score of 7. The company holds a Beta of 1.33, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Profound Medical will likely underperform. Please check Profound Medical's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Profound Medical's historical price patterns will revert.